Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which ...

TEPEZZA, as the first FDA-approved treatment for thyroid eye disease, marks a major breakthrough in managing TED, addressing a critical medical gap for patients who have long had few treatment ...

Li, Y. and Zhou, B. (2025) Research Progress on the Relationship between Dynapenic Obesity and Type 2 Diabetes. Journal of Biosciences and Medicines, 13, 256-267. doi: 10.4236/jbm.2025.132020 .

Heterocyclic insulin-like growth factor 1 receptor (IGF-1R; CD221) inhibitors potentially useful for the treatment of thyroid-associated ophthalmopathy (Graves’ ophthalmopathy) have been disclosed in ...

Secondary lymphedema occurs when, after surgery or radiotherapy, the lymphatic system cannot drain interstitial fluid effectively, leading to inflammation and fluid accumulation in the limbs. Previous ...

Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.

Results: The keratinocyte migration and viability increased after treatment with the growth factors insulin-like growth factor 1 (IGF-1) and keratinocyte growth factor (KGF). A similar effect was ...

Peptides have gained significant attention in research due to their possible role in regulating various physiological processes. Among these, Ipamorelin and Growth Hormone hormone-releasing peptide-2 ...

Malignant T-cell transformation after chimeric antigen receptor (CAR ... 9,10 The treatment course was notable for grade 1 cytokine release syndrome and resulted in a minimal residual disease ...

Open-label arm (infant participants < 1 year old) has been recently reviewed by a Data Monitoring Committee (DMC) and target drug ...